U.S. Consumer Durables Stock News

Before you make any moves with Caterpillar, it helps to ask a simple question: is the current share price actually giving you fair value for what you are buying? Caterpillar shares last closed at US$596.52, with returns of 4.1% over the past week, 0.0% over the past month, a 0.3% decline year to date, and 67.7% over the past year. The shares are also up 150.4% over three years and 234.9% over five years, which will naturally get investors thinking about both upside potential and changing...

What Berkshire Hathaway’s Latest Numbers Tell You Right Now Berkshire Hathaway (BRK.B) recently drew attention as its shares closed at $496.12, with one-day and past-week returns slightly negative, inviting a closer look at how the conglomerate’s current fundamentals line up. See our latest analysis for Berkshire Hathaway. Recent trading has been fairly muted, with the share price return over the past month and quarter close to flat, while the 1 year total shareholder return of 9.8% and 5...

Why Monte Rosa Therapeutics Is Drawing Investor Attention Monte Rosa Therapeutics (GLUE) has been on investors’ radar after recent trading performance, with the stock showing strong returns over the past month and past 3 months. This has prompted fresh questions about how the current price reflects fundamentals. See our latest analysis for Monte Rosa Therapeutics. Beyond the recent spike, Monte Rosa Therapeutics has seen a 131.87% 90 day share price return and a very large 288.65% 1 year...

Clorox (CLX) is back in focus as investors look ahead to its upcoming fiscal Q2 2026 earnings, after the company previously topped Wall Street profit expectations despite revenue pressures and operational disruptions. See our latest analysis for Clorox. At a share price of $101.76, Clorox has seen short term momentum soften after earlier gains, with a 90 day share price return of a 15.2% decline alongside a 1 year total shareholder return loss of 34.27%, as investors weigh its earnings beat,...

Wondering if CAVA Group at around US$67.90 is a bargain, a bubble, or somewhere in between? This article walks through what the current price may be implying about the stock. The share price has moved sharply in the short term, with a 15.7% return over the last week and 26.1% over the last month, while the 1 year return sits at a 40.7% decline. Recent coverage around CAVA Group has focused on its position as a fast casual Mediterranean brand and its profile as a relatively new public...

If you are wondering whether Quest Diagnostics at around US$178 per share represents good value today, looking closely at what you are paying for each dollar of its business can be a useful next step. The stock has recently shown mixed returns, with a 2.7% gain over the last 7 days, a 2.0% decline over the last 30 days, and returns of 2.5% year to date, 17.8% over 1 year, 23.8% over 3 years, and 56.6% over 5 years. Recent coverage of Quest Diagnostics has focused on its role in diagnostic...

If you have been watching TowneBank and wondering whether the recent price levels still make sense, this article will help you weigh up what you are really paying for each dollar of its business. The stock last closed at US$34.08, with returns of 2.1% over the past week, a 0.7% decline over the past month, 2.6% year to date, 6.0% over one year, 22.3% over three years and 57.9% over five years, which may have you asking whether the current price fairly reflects the underlying...

In late 2025, Hecla Mining announced that Senior Vice President and Chief Administrative Officer Michael L. Clary would step down and transition to a consulting role from January 1, 2026, while the company prepared an Investor Day in New York City to outline its strategy, operations, and sustainability priorities. At the same time, rising silver prices driven by safe-haven demand amid geopolitical tensions and improving earnings estimates have increased attention on how Hecla’s...

If you are wondering whether Charles Schwab's current share price offers good value or is already pricing in a lot of optimism, this article will walk through the key signals you can use to frame that decision. With the stock last closing at US$101.93 and returns of 2.0% over 7 days, 8.1% over 30 days, 0.4% year to date, 41.3% over 1 year, 27.6% over 3 years, and 82.8% over 5 years, many investors are asking how much of this performance is already reflected in today's price. Recent coverage...

Cigna Group (CI) remains in focus for investors after recent trading left the stock around $279.12, with returns mixed across different periods and financial results that include revenue of about $268.1 billion and net income of roughly $6.1 billion. See our latest analysis for Cigna Group. Recent trading has been choppy, with a 1 day share price return of about a 2% decline and a 90 day share price return of an 8.8% decline. The 5 year total shareholder return of 36.3% points to steadier...

RXO, Inc. recently reported quarterly results that showed stronger revenue and a much smaller GAAP loss than a year earlier, and held a follow-up conference call to discuss performance. Analysts highlighted that these operational gains, combined with recent insider share purchases, have improved confidence in RXO’s progress even as they continue to flag margin pressures and freight market headwinds. Now we will examine how RXO’s improved quarterly performance and insider buying affect the...

If you are wondering whether Chewy’s current share price reflects its real worth, you are not alone. This article is designed to help you think that through clearly. Chewy most recently closed at US$32.00, after share price returns of a 3.2% decline over 7 days, a 7.6% decline over 30 days, a 4.4% decline year to date, an 11.6% decline over 1 year, a 26.9% decline over 3 years and a 71.5% decline over 5 years. These moves sit against a backdrop of ongoing attention on Chewy’s role in the US...

If you are wondering whether International Paper is offering good value right now, you are not alone. This is especially true with sentiment around packaging and materials stocks constantly shifting. The share price recently closed at US$39.56, with returns of 0.4% over 7 days, 2.7% over 30 days, a 1.7% decline year to date, and a 24.7% decline over 1 year, while the 3 year and 5 year returns sit at 20.6% and 2.1% respectively. Recent coverage around International Paper has focused on its...

If you are wondering whether Intuit's share price still reflects its underlying worth after a strong multi year run, this article walks through what the current numbers actually say about value. At a last close of US$651.15, the stock has seen a 1.7% decline over the past 7 days and a 0.8% decline over 30 days, while returns sit at 3.4% year to date, 4.7% over 1 year, 67.7% over 3 years and 83.8% over 5 years. Recent coverage has focused on Intuit's position as a key player in tax and...

In recent months, an analyst reiterated a positive view on S&P Global, highlighting expectations that the company could benefit from increased debt financing activity supported by lower interest rates and a backlog of IPOs. A separate update from S&P Dow Jones Indices showed that net indicated dividend changes for U.S. domestic common stocks rose by US$13.10 billion in Q4 2025, underlining how broader market activity may tie into S&P Global’s information and index businesses. Next, we’ll...

Oscar Health (OSCR) drew fresh attention after Barclays shifted to a more neutral stance on the stock, citing attractive pricing, reduced policy risk concerns, and potential profit margin expansion across the managed care sector. See our latest analysis for Oscar Health. Barclays’ upgrade fits into a mixed year for Oscar Health, with a 7 day share price return of 14.68% and a 10.09% year to date share price return. At the same time, the 3 year total shareholder return is very large,...

Wondering if Exelixis at a last close of US$46.19 still offers value, or if the easy money has already been made? This article walks through what the numbers are actually saying about the stock. Over the shorter term, Exelixis has posted returns of 5.4% over 7 days, 9.5% over 30 days, 6.0% year to date, 33.9% over 1 year and 175.1% over 3 years. Its 5 year return of 89.5% gives a broader context to the recent share price move. Recent coverage around Exelixis has focused on its position in...

Quest Diagnostics Incorporated ( NYSE:DGX ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is...

In early January 2026, TransUnion received public criticism from the Federal Housing Finance Agency over its credit reporting pricing practices, following complaints that mortgage originators were facing sharp increases in credit reporting costs and calls to reduce the number of required reports for some borrowers. Around the same time, TransUnion appointed former Capital One executive Francesca Noli to lead its Global Consumer Solutions TruEmpower portfolio, highlighting a push to expand...

Hancock Whitney Corporation recently appointed Emory Mayfield as Chief Banking Officer, placing him in charge of core businesses spanning corporate, middle market, commercial, business, mortgage, and retail banking, reporting to President and COO D. Shane Loper. Mayfield’s progression from regional leadership roles to Chief Consumer Banking Officer and now Chief Banking Officer underscores how the bank is elevating an insider with deep institutional knowledge to oversee its primary revenue...

In early January 2026, Automatic Data Processing reported that its private payrolls increased by 41,000 in December, reversing a 29,000 decline in November, with services sectors such as education, health services, and leisure and hospitality driving most of the gains. This rebound in ADP-tracked hiring is being watched closely as a potential indicator of resilient labor demand ahead of official US employment data releases. We’ll now examine how December’s stronger private payroll growth,...

Recent geopolitical shifts have reshaped global shipping patterns, with trade disruptions and rerouted flows increasing demand for containership capacity in the past months, benefiting asset owners such as Global Ship Lease. As containerized trade fragments and supply chains grow more complex, midsize and smaller vessels at the heart of Global Ship Lease’s fleet appear increasingly relevant for meeting flexible, diversified transport needs. We’ll now examine how heightened trade-route...

In recent days, Invesco Ltd. announced that it will release its fourth-quarter 2025 results on January 27, 2026, alongside a US$500 million preference share buyback at an 18% premium, ongoing fund dividends, and an expanded private-markets partnership with LGT Capital Partners. These capital management actions and the push into private markets indicate a clear effort to reshape Invesco’s balance sheet while broadening higher-fee alternative investment access for U.S. clients. With this...

Healthcare Realty Trust has appointed investment banker Daniel Gabbay as Chief Financial Officer and Executive Vice President, effective January 12, 2026, while current CFO Austen Helfrich will depart without any reported disagreements with management or auditors. Gabbay’s deep healthcare REIT investment banking background, including advising on multi‑billion‑dollar sector mergers, introduces a finance leader with extensive capital markets and transaction experience at a time of ongoing...